Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up

The purpose of the present one-year follow-up study was to describe and investigate the change in the amount of antipsychotic drugs prescribed for ACT (assertive community treatment) clients in Japan. Subjects were 52 clients of ACT from January 2009 to December 2009. Prescription data were collecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Satake, Naoko, Hazama, Kyoko, Sono, Tamaki, Takahashi, Makoto, Ito, Junichiro
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087967/
https://www.ncbi.nlm.nih.gov/pubmed/21552480
http://dx.doi.org/10.2174/1745017901107010001
_version_ 1782202840815501312
author Satake, Naoko
Hazama, Kyoko
Sono, Tamaki
Takahashi, Makoto
Ito, Junichiro
author_facet Satake, Naoko
Hazama, Kyoko
Sono, Tamaki
Takahashi, Makoto
Ito, Junichiro
author_sort Satake, Naoko
collection PubMed
description The purpose of the present one-year follow-up study was to describe and investigate the change in the amount of antipsychotic drugs prescribed for ACT (assertive community treatment) clients in Japan. Subjects were 52 clients of ACT from January 2009 to December 2009. Prescription data were collected each month from the time the clients entered into ACT. The results of a Wilcoxon signed-rank test show that the dosage of antipsychotics significantly decreased from 1,131.3 mg to 731.3 mg over the course of the 12 months (Z = -2.505, p = 0.012).
format Text
id pubmed-3087967
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-30879672011-05-06 Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up Satake, Naoko Hazama, Kyoko Sono, Tamaki Takahashi, Makoto Ito, Junichiro Clin Pract Epidemiol Ment Health Article The purpose of the present one-year follow-up study was to describe and investigate the change in the amount of antipsychotic drugs prescribed for ACT (assertive community treatment) clients in Japan. Subjects were 52 clients of ACT from January 2009 to December 2009. Prescription data were collected each month from the time the clients entered into ACT. The results of a Wilcoxon signed-rank test show that the dosage of antipsychotics significantly decreased from 1,131.3 mg to 731.3 mg over the course of the 12 months (Z = -2.505, p = 0.012). Bentham Open 2011-01-19 /pmc/articles/PMC3087967/ /pubmed/21552480 http://dx.doi.org/10.2174/1745017901107010001 Text en © Satake et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Satake, Naoko
Hazama, Kyoko
Sono, Tamaki
Takahashi, Makoto
Ito, Junichiro
Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up
title Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up
title_full Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up
title_fullStr Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up
title_full_unstemmed Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up
title_short Changes in Antipsychotic Medication in Clients of Assertive Community Treatment in Japan: A One-Year Follow Up
title_sort changes in antipsychotic medication in clients of assertive community treatment in japan: a one-year follow up
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087967/
https://www.ncbi.nlm.nih.gov/pubmed/21552480
http://dx.doi.org/10.2174/1745017901107010001
work_keys_str_mv AT satakenaoko changesinantipsychoticmedicationinclientsofassertivecommunitytreatmentinjapanaoneyearfollowup
AT hazamakyoko changesinantipsychoticmedicationinclientsofassertivecommunitytreatmentinjapanaoneyearfollowup
AT sonotamaki changesinantipsychoticmedicationinclientsofassertivecommunitytreatmentinjapanaoneyearfollowup
AT takahashimakoto changesinantipsychoticmedicationinclientsofassertivecommunitytreatmentinjapanaoneyearfollowup
AT itojunichiro changesinantipsychoticmedicationinclientsofassertivecommunitytreatmentinjapanaoneyearfollowup

Ejemplares similares